Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Elliot Sigal. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Elliot Sigal har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ONCE / Spark Therapeutics, Inc. Director 0
US:MJN / Mead Johnson Nutrition Co. Director 0
US:BMY / Bristol-Myers Squibb Company EVP, CSO & President R&D, Director 25.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Elliot Sigal. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Elliot Sigal som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -25.786 0 -100,00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -17.203 0 -100,00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -6.000 0 -100,00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -4.000 0 -100,00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -4.000 0 -100,00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Common Stock
U - Other -14.214 0 -100,00 114,50 -1.627.503
2019-06-03 2019-05-30 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
M - Exercise -1.500 0 -100,00
2019-06-03 2019-05-30 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 1.500 14.214 11,80
2018-05-31 2018-05-31 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
M - Exercise -1.500 0 -100,00
2018-05-31 2018-05-31 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 1.500 12.714 13,38
2018-05-31 2018-05-30 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
A - Award 4.000 4.000
2018-05-31 2018-05-30 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
A - Award 1.500 1.500
2018-04-16 2017-11-28 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale -29 11.214 -0,26 72,43 -2.100 812.230
2018-04-16 2017-10-12 4 ONCE Spark Therapeutics, Inc.
Common Stock
P - Purchase 29 11.243 0,26 90,75 2.632 1.020.302
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Restricted Stock Units
D - Sale to Issuer -1.709 0 -100,00 90,00 -153.810
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Common Stock
D - Sale to Issuer -5.180 0 -100,00 90,00 -466.200
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Common Stock
D - Sale to Issuer -5.180 0 -100,00 90,00 -466.200
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Common Stock
D - Sale to Issuer -2.590 0 -100,00 90,00 -233.100
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Common Stock
D - Sale to Issuer -13.721 0 -100,00 90,00 -1.234.890
2017-06-02 2017-05-31 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
A - Award 1.500 1.500
2017-06-02 2017-05-31 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
A - Award 4.000 4.000
2017-03-02 2017-03-01 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -2.373 0 -100,00
2017-03-02 2017-03-01 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 2.373 13.721 20,91
2017-03-02 2017-02-28 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
A - Award 1.709 1.709
2016-06-03 2016-06-01 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
A - Award 6.000 6.000
2016-03-01 2016-02-29 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise 2.373 2.373
2016-03-01 2016-02-26 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -1.678 0 -100,00
2016-03-01 2016-02-26 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 1.678 11.348 17,35
2015-03-03 2015-02-28 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -2.146 0 -100,00
2015-03-03 2015-02-28 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 2.146 9.670 28,52
2015-02-27 2015-02-26 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
A - Award 1.678 1.678
2015-02-06 2015-02-04 4 ONCE Spark Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -31.559 0 -100,00
2015-02-06 2015-02-04 4 ONCE Spark Therapeutics, Inc.
Series B Preferred Stock
A - Award 503 31.559 1,62
2015-02-06 2015-02-04 4 ONCE Spark Therapeutics, Inc.
Common Stock
P - Purchase 5.000 11.214 80,46 23,00 115.000 257.922
2015-02-06 2015-02-04 4 ONCE Spark Therapeutics, Inc.
Common Stock
C - Conversion 31.559 31.559
2015-01-29 3 ONCE Spark Therapeutics, Inc.
Common Stock
12.428
2015-01-29 3 ONCE Spark Therapeutics, Inc.
Common Stock
12.428
2014-03-03 2014-02-28 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
A - Award 2.146 2.146
2014-03-03 2014-02-27 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -1.876 0 -100,00
2014-03-03 2014-02-27 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 1.876 7.524 33,22
2013-06-05 2013-06-03 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -98.875 25.000 -79,82
2013-06-05 2013-06-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -83.647 148.221 -36,08 48,18 -4.030.112 7.141.288
2013-06-05 2013-06-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 98.875 231.868 74,35 27,01 2.670.614 6.262.755
2013-05-31 2013-05-30 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -50.000 0 -100,00
2013-05-31 2013-05-30 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -120.625 123.875 -49,34
2013-05-31 2013-05-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -143.521 132.993 -51,90 47,23 -6.778.497 6.281.259
2013-05-31 2013-05-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 50.000 276.514 22,07 24,74 1.237.000 6.840.956
2013-05-31 2013-05-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 120.625 226.514 113,92 27,01 3.258.081 6.118.143
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -202.405 50.000 -80,19
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -103.500 0 -100,00
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -459 9.091 -4,81 39,65 -18.199 360.458
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -919 18.180 -4,81 39,65 -36.438 720.837
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -919 18.180 -4,81 39,65 -36.438 720.837
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -175.143 105.889 -62,32 39,61 -6.937.414 4.194.263
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -90.234 281.032 -24,30 39,61 -3.574.169 11.131.678
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -88.132 371.266 -19,18 39,63 -3.492.671 14.713.272
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 103.500 459.398 29,08 25,45 2.634.075 11.691.679
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 202.405 355.898 131,87 24,74 5.007.500 8.804.917
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -36.503 252.405 -12,63
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -11.092 288.908 -3,70
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -25.795 0 -100,00
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -9.157 9.550 -48,95 39,97 -366.005 381.714
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -18.313 19.099 -48,95 39,97 -731.971 763.387
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -18.313 19.099 -48,95 39,97 -731.971 763.387
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -41.868 153.493 -21,43 39,92 -1.671.371 6.127.441
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -31.594 195.361 -13,92 39,90 -1.260.601 7.794.904
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -21.856 226.955 -8,78 39,90 -872.054 9.055.504
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -9.600 248.811 -3,72 40,00 -384.000 9.952.440
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 11.092 258.411 4,48 24,74 274.416 6.393.088
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 25.795 247.319 11,64 22,73 586.320 5.621.561
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 36.503 221.524 19,73 24,74 903.084 5.480.504
2013-03-11 2013-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
A - Award 29.630 29.630
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 845 22.011 3,99
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 21.166 21.166
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 2.466 64.243 3,99
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 27.866 61.777 82,17
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
M - Exercise -99.812 0 -100,00
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 3.832 99.812 3,99
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 29.007 95.980 43,31
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -8.801 26.406 -25,00
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -12.062 35.491 -25,37
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -11.715 47.553 -19,77
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -51.754 185.021 -21,86 37,53 -1.942.328 6.943.838
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -9.343 236.775 -3,80 37,53 -350.643 8.886.166
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -8.748 246.118 -3,43 37,53 -328.312 9.236.809
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -5.194 254.866 -2,00 37,53 -194.931 9.565.121
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 1.216 260.060 0,47
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 5.156 258.844 2,03
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 5.957 253.688 2,40
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 8.801 247.731 3,68
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 11.715 238.930 5,16
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 12.062 227.215 5,61
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 99.812 215.153 86,54
2013-03-05 2013-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -7.453 0 -100,00
2013-03-05 2013-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -3.865 115.341 -3,24 36,94 -142.773 4.260.697
2013-03-05 2013-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 7.453 119.206 6,67
2013-03-05 2013-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -46.365 46.367 -50,00
2013-03-05 2013-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -24.041 111.753 -17,70 37,15 -893.123 4.151.624
2013-03-05 2013-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 46.365 135.794 51,85
2013-03-04 2013-03-02 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -1.789 0 -100,00
2013-03-04 2013-03-02 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 1.789 5.648 46,36
2013-03-04 2013-02-27 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
A - Award 1.876 1.876
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Option (right to buy)
M - Exercise -48.333 0 -100,00
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -70.000 25.795 -73,07
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -147.749 0 -100,00
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -224.705 89.429 -71,53 36,79 -8.266.897 3.290.093
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 48.333 314.134 18,18 28,11 1.358.641 8.830.307
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 70.000 265.801 35,75 22,73 1.591.100 6.041.657
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 147.749 195.801 307,48 17,51 2.587.085 3.428.476
2012-12-13 2012-12-11 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -62.903 37.412 -62,71 33,00 -2.075.799 1.234.596
2012-12-13 2012-12-11 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -62.903 37.412 -62,71 33,00 -2.075.799 1.234.596
2012-12-13 2012-12-11 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -31.451 18.707 -62,70 33,00 -1.037.883 617.331
2012-12-13 2012-11-27 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
G - Gift 100.315 100.315
2012-12-13 2012-11-27 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
G - Gift 100.315 100.315
2012-12-13 2012-11-27 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
G - Gift -200.630 50.158 -80,00
2012-12-03 2012-11-27 4 MJN Mead Johnson Nutrition Co
Common Stock
G - Gift 5.180 5.180
2012-12-03 2012-11-27 4 MJN Mead Johnson Nutrition Co
Common Stock
G - Gift 5.180 5.180
2012-12-03 2012-11-27 4 MJN Mead Johnson Nutrition Co
Common Stock
G - Gift -10.360 2.590 -80,00
2012-09-14 2012-01-03 4 MJN Mead Johnson Nutrition Co
Common Stock
J - Other -4 0 -100,00 71,35 -282
2012-09-14 2012-01-03 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 4 4 71,35 282 282
2012-09-14 2011-12-20 4 MJN Mead Johnson Nutrition Co
Common Stock
J - Other -1.083 0 -100,00 74,19 -80.361
2012-09-14 2011-10-03 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 4 1.083 0,37 68,11 275 73.779
2012-09-14 2011-07-01 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 4 1.079 0,38 69,04 282 74.508
2012-09-14 2011-04-01 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 5 1.075 0,45 58,33 279 62.711
2012-09-14 2011-01-03 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 4 1.070 0,36 62,30 238 66.681
2012-09-14 2010-10-01 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 4 1.067 0,40 56,25 240 59.991
2012-09-14 2010-07-01 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 5 1.062 0,45 50,53 241 53.675
2012-09-14 2010-04-01 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 5 1.057 0,43 52,90 241 55.940
2012-09-14 2010-01-15 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 4 1.053 0,42 46,81 208 49.287
2012-09-14 2009-12-29 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 9 1.048 0,84 44,58 389 46.741
2012-09-07 2012-09-05 4 MJN Mead Johnson Nutrition Co
Common Stock
J - Other -12.950 16.809 -43,52
2012-09-07 2012-09-05 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other -250.788 298.840 -45,63
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -6.875 0 -100,00
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 1.457 33.911 4,49
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 32.454 32.454
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
M - Exercise -78.955 66.973 -54,11
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 2.879 145.928 2,01
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 28.152 143.049 24,50
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 33.783 114.897 41,65
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
A - Award 35.207 35.207
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -36.597 298.840 -10,91 32,33 -1.183.181 9.661.497
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -3.187 335.437 -0,94 32,33 -103.036 10.844.678
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 6.875 338.624 2,07
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 78.955 331.749 31,23
2012-03-06 2012-03-02 4 MJN Mead Johnson Nutrition Co
Restricted Stock Units
M - Exercise -1.699 1.789 -48,71 78,26 -132.964 140.007
2012-03-06 2012-03-02 4 MJN Mead Johnson Nutrition Co
Restricted Stock Units
A - Award 1.789 3.488 105,30
2012-03-06 2012-03-02 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 1.699 16.809 11,24 78,26 132.964 1.315.472
2012-03-05 2012-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -7.453 7.453 -50,00
2012-03-05 2012-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -3.455 252.794 -1,35 32,59 -112.598 8.238.556
2012-03-05 2012-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 7.453 256.249 3,00
2012-03-05 2012-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -46.365 92.732 -33,33
2012-03-05 2012-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -21.491 248.796 -7,95 32,59 -700.392 8.108.262
2012-03-05 2012-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 46.365 270.287 20,71
2012-03-05 2012-03-02 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -12.062 59.268 -16,91
2012-03-05 2012-03-02 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -7.383 223.922 -3,19 32,59 -240.612 7.297.618
2012-03-05 2012-03-02 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 3.866 231.305 1,70
2012-03-05 2012-03-02 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 12.062 227.439 5,60
2012-03-05 2012-03-01 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -11.714 71.330 -14,11
2012-03-05 2012-03-01 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -5.412 215.377 -2,45 32,64 -176.648 7.029.905
2012-03-05 2012-03-01 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 3.173 220.789 1,46
2012-03-05 2012-03-01 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 11.714 217.616 5,69
2011-12-29 2010-03-06 4/A BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -6.875 13.750 -33,33
2009-03-12 3 MJN Mead Johnson Nutrition Co
Common Stock
5.000
2003-08-04 2003-08-01 4 (BMY) BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -1.219 75.024 -1,60
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)